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Increasing evidence indicates that patients with obsessive-compulsive disorder (OCD)
exhibit alterations in fronto-striatal circuitry. Performance deficits in the antisaccade task
would support this model, but results from previous small-scale studies have been
inconclusive as either increased error rates, prolonged antisaccade latencies, both
or neither have been reported in OCD patients. In order to address this issue, we
investigated antisaccade performance in a large sample of OCD patients (n = 169)
and matched control subjects (n = 183). As impaired antisaccade performance
constitutes a potential endophenotype of OCD, unaffected first-degree relatives of OCD
patients (n = 100) were assessed, as well. Furthermore, we conducted a quantitative
meta-analysis to integrate our data with previous findings. In the empirical study, OCD
patients exhibited significantly increased antisaccade latencies, intra-subject variability
(ISV) of antisaccade latencies, and antisaccade error rates. The latter effect was driven
by errors with express latency (80–130ms), as patients did not differ significantly
from controls with regards to regular errors (>130ms). Notably, unaffected relatives
of OCD patients showed elevated antisaccade express error rates and increased
ISV of antisaccade latencies, as well. Antisaccade performance was not associated
with state anxiety within groups. Among relatives, however, we observed a significant
correlation between antisaccade error rate and harm avoidance. Medication status of
OCD patients, symptom severity, depressive comorbidity, comorbid anxiety disorders
and OCD symptom dimensions did not significantly affect antisaccade performance.
Meta-analysis of 10 previous and the present empirical study yielded a medium-sized
effect (SMD = 0.48, p < 0.001) for higher error rates in OCD patients, while the effect
for latencies did not reach significance owing to strong heterogeneity (SMD = 0.51,
p = 0.069). Our results support the assumption of impaired antisaccade performance
in OCD, although effects sizes were only moderately large. Furthermore, we provide the
Bey et al. Antisaccades in Obsessive-Compulsive Disorder
first evidence that increased antisaccade express error rates and ISV of antisaccade
latencies may constitute endophenotypes of OCD. Findings regarding these more
detailed antisaccade parameters point to potentially underlying mechanisms, such as
early pre-stimulus inhibition of the superior colliculus.
Keywords: obsessive-compulsive disorder, OCD, antisaccade, endophenotype, meta-analysis, eye-tracking
INTRODUCTION
Obsessive-compulsive disorder (OCD) is a debilitating
and often chronic psychiatric disorder characterized by
obsessions (recurrent intrusive thoughts and/or images) and/or
compulsions (ritualized repetitive behaviors), that affects 1–3%
of the population worldwide (1). OCD is familial (2) with
first-degree relatives having an approximately 5-fold increased
risk of also being affected by the disease (3–5). Converging
evidence from neuroimaging studies has suggested that altered
functioning of the cortico-striato-thalamo-cortical (CSTC)
circuits, including the orbitofrontal cortex (OFC), anterior
cingulate cortex (ACC), basal ganglia and the thalamus, is
implicated in the pathophysiology of OCD (6, 7). Specifically,
an imbalance between the direct and indirect pathways within
the CSTC circuits leads to an excess tone in the former over the
latter, resulting in disturbances of executive functioning that may
underlie features of the symptomatology of OCD (8). While the
direct loop functions as a self-reinforcing positive feedback loop
and contributes to the initiation and continuation of behaviors,
the indirect loop serves as a mechanism of negative feedback,
which is implicated in the inhibition of behaviors and in adaptive
switching between behaviors (9, 10). The CSTC model of OCD
thus predicts that affected individuals will be characterized by
impaired performance in executive function tasks that demand
the initiation of a volitional response while inhibiting a prepotent
response.
A well-established approach to investigating those functions
is the antisaccade task (11), which requires subjects to suppress
a reflexive saccade toward a peripherally appearing stimulus
in order to make a volitional eye movement in the opposite
direction. As a control condition featuring the same setup but
with no inhibitory demands, the prosaccade task has been
used, which instructs the subject to look toward the appearing
stimulus. While OCD patients perform normally with respect
to prosaccade tasks in terms of error rates, latencies [for a
review, see (12)] and intra-subject variability (ISV) of latencies
(13), research employing the antisaccade task provides more
mixed results, with a range of studies describing deficits in either
error rates, latencies, both or neither (14–23). Inconsistencies
in results may be explained by a variety of factors, including
differences in task design parameters and sample characteristics.
Across patients, obsessive-compulsive symptoms are highly
heterogeneous, covering dimensions of washing/contamination,
ordering/symmetry, forbidden thoughts and hoarding (24),
which are all associated with differences in brain structure (25),
brain function (26, 27) and neuropsychological performance
(28). The interpretation of findings pertaining to the antisaccade
task is further hindered by the tendency to utilize small
sample sizes so that in certain cases, non-significant group
differences might reflect poor statistical power rather than an
absence of effect. Still, a quantitative meta-analysis of antisaccade
performance in OCD is lacking, and the examination of larger
samples of well-characterized OCD patients is warranted. The
investigation of antisaccade performance in OCD could also
benefit from examining more fine-grained outcome measures,
like, for example, by subdividing direction errors into express
errors and regular errors as distinct mechanisms appear to act
as the foundation of these different types of errors (29). Errors
with express latency (≤130ms) result from failed preparatory
suppression of the superior colliculus that must be present prior
to stimulus appearance in order to prevent a reflexive orienting
response toward the peripheral stimulus. Errors with regular
latency (>130ms), on the other hand, result from failure in active
suppression of an automated saccade plan and the generation
of a voluntary saccade to an abstract location. As these detailed
saccade parameters have not been investigated in OCD patients
so far, the analysis of express and regular error rates may point
to specific neural mechanism deficient in OCD. Furthermore,
functional and structural aberrations in OCD are not restricted
to “executive” loops within the CSTC circuitry but also concern
interconnected “affective” circuits that underlie functions of
reward sensitivity, fear extinction and anxiety proneness (30,
31). Considering anxiety-related traits like harm avoidance in
the context of antisaccade research may hence yield additional
insights.
As response inhibition has been proposed as a potential
endophenotype of OCD, the assessment of unaffected first-
degree relatives might also prove fruitful in the search for
the biological underpinnings of OCD. Endophenotypes are
quantitative variables (e.g., cognitive or neurophysiological)
associated with the disease while being distinct from the
clinical phenotype itself (32). They are supposed to depend
upon variation in fewer genes than the more complex disease
phenotype and are therefore assumed to be more tractable
to genetic analysis. Within families, endophenotypes and the
disorder co-segregate, so that unaffected relatives are expected
to show abnormalities similar to those observed in patients. In
line with this concept, both OCD patients and relatives exhibit
deficits in performance monitoring (33), planning capacity (34),
cognitive flexibility (34–36) and response inhibition as evaluated
with the Stop Signal Task (35, 37) and the Stroop Task (36).
Most notably, Lennertz et al. (17) recently reported deficient
antisaccade performance in OCD patients as well as in their
unaffected first-degree relatives in terms of both elevated error
rates and increased antisaccade latencies.
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In the present study, we aimed to investigate whether patients
with OCD and their first-degree relatives exhibit deficits in the
antisaccade task by assessing error rates, mean latencies and ISV
of latencies in a large and well-characterized sample. In addition,
we conducted a quantitative meta-analysis to integrate our data
with previous findings and quantify random and systematic




One hundred and sixty-nine patients with OCD, 183 healthy
comparison subjects and 100 unaffected first-degree relatives of
OCD patients (n = 67 parents; n = 25 siblings; n = 8 offspring)
participated in the study. Patients and controls were matched for
age, gender and education. Relatives were significantly older than
patients and controls (see Table 1 for sample characteristics).
OCD patients and relatives were recruited via the outpatient
clinics at the Department of Psychology of Humboldt-Universität
zu Berlin and at the Department of Psychiatry and Psychotherapy
of the University of Bonn, Germany. Healthy volunteers were
recruited from the general population via public advertisements.
A total of 279 subjects were assessed in Berlin (n = 101
OCD patients; n = 54 unaffected relatives; n = 124 control
subjects) and 171 subjects were assessed in Bonn (n = 68
OCD patients; n = 46 unaffected relatives; n = 59 control
subjects). All participants were examined by trained clinical
psychologists using the Structured Clinical Interview for DSM-
IV [SCID-I; (38, 39)]. To establish cross-site reliability of
clinical ratings, all instructions were standardized and raters
completed assessments of four training videos. Patients and
relatives were only included if they were: (a) free of past or
present psychotic, bipolar or substance-related disorders; (b) did
not take neuroleptic medication for the previous 4 weeks; and (c)
did not use benzodiazepines in the prior 2 weeks. Additionally,
healthy controls were excluded if they: (a) took any psychoactive
medication in the previous 3 months; (b) had a current Axis I
disorder; (c) had a lifetime diagnosis of OCD or tic disorder; or
(d) had a family history of OCD. All relatives were free of past or
present OCD.
Seventy-six OCD patients were medicated, with n = 62
taking selective serotonin reuptake inhibitors (SSRIs) and n= 33
receiving other antidepressants over the previous 4 weeks. Sixty-
five patients were medication-naïve. Furthermore, the majority
of patients had one or more comorbid Axis I disorders, with
major depression being the most common comorbidity (n = 37
current episode; n = 66 remitted). Other current comorbidities
included: panic disorder (n = 3 with agoraphobia; n = 5
without agoraphobia), social phobia (n = 13), specific phobia
(n = 12), generalized anxiety disorder (n = 7), posttraumatic
stress disorder (n = 6), attention deficit/hyperactivity disorder
(n = 3), anorexia nervosa (n = 1), binge eating disorder
(n = 2), tic disorder (n = 13), skin picking disorder (n = 10),
hypochondria (n = 5), body dysmorphic disorder (n = 2),
hoarding disorder (n= 4), pain disorder (n= 1), and unspecified
somatoform disorder (n= 6).
The severity of OCD symptoms was evaluated with the
German versions of the Yale-Brown Obsessive-Compulsive
Scale [Y-BOCS; (40, 41)] and the Obsessive-Compulsive
Inventory-Revised [OCI-R; (42, 43)]. Symptom dimensions
were measured via the Y-BOCS Symptom Checklist [Y-BOCS
CL; (40)]. The Montgomery Asberg Depression Rating Scale
[MADRS;(44, 45)] and the Beck Depression Inventory-II [BDI-
II; (46, 47)] were employed to assess the severity of current
depressive symptoms. To account for potential effects of state
anxiety, the State-Trait Anxiety Inventory [STAI; (48, 49)] was
administered. Harm avoidance was assessed using the German
version of the Temperament and Character Inventory [TCI;
(50, 51)]. All participants had normal or corrected-to-normal
vision and were free of any neurological disease
(lifetime).
TABLE 1 | Demographic and clinical characteristics of patients with OCD, unaffected first-degree relatives and healthy control subjects.
Patients with OCD Unaffected first-degree relatives Healthy control subjects Statistic p
N 169 100 183
Mean age, years (SD) 32.69 (10.44) [18–64] 46.55 (13.73) [18–67] 34.20 (12.70) [18–64] F (2, 449) = 45.72 <0.001
Gender, % male 43.2 31.0 37.7 X2(2) = 4.00 0.14
Education (SD)a 4.90 (1.81) [1–7] 4.78 (2.00) [1–7] 5.17 (1.60) [1–7] F (2, 447) = 1.88 0.15
Mean OCI-R score (SD) 27.76 (12.22) [5–64] 7.11 (6.76) [0–35] 4.57 (4.51) [0–22] F (2, 449) = 357.15 <0.001
Mean BDI-II score (SD) 18.46 (10.60) [0–45] 5.88 (6.96) [0–28] 2.96 (3.64) [0–18] F (2, 449) = 195.59 <0.001
Mean state anxiety score (SD) 42.32 (9.69) [22–72] 33.80 (7.52) [22–60] 31.39 (5.97) [20–52] F (2, 448) = 89.35 <0.001
Mean harm avoidance score (SD) 22.34 (6.65) [3–35] 14.61 (6.51) [1–31] 10.77 (5.22) [0–25] F (2, 445) = 160.33 <0.001
Mean MADRS score (SD)b 11.60 (8.60) [0–41]
Mean Y-BOCS score (SD)b 22.03 (6.71) [0–35]c
Mean age of onset (SD)b 20.93 (11.01) [3–59]
The range of scores is indicated in brackets. BDI-II, Beck Depression Inventory-II; MADRS, Montgomery Asberg Depression Rating Scale; OCD, obsessive-compulsive disorder; OCI-R,
Obsessive-Compulsive Inventory-Revised; SD, standard deviation; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.
aEducation was assessed on a scale from 1 to 7.
bMADRS, Y-BOCS and age of onset were only assessed in patients.
cOne patient had severe OCD in the past, but was fully remitted at the time of testing.
Frontiers in Psychiatry | www.frontiersin.org 3 June 2018 | Volume 9 | Article 284
Bey et al. Antisaccades in Obsessive-Compulsive Disorder
Written informed consent was obtained and participants were
compensated for their time. The study was in accordance with
the revised Declaration of Helsinki and approved by the local
ethics committees of the Charité Universitätsmedizin Berlin and
the University Clinic Bonn.
Eye Movement Recordings
Testing took place in a quiet, dimly lit room. Participants were
seated comfortably in front of a 22-inch liquid crystal display
(LCD) monitor (Viewsonic; height: 29.5 cm; width: 47.5 cm;
resolution: 1,680 × 1,050 pixels; 60Hz refresh rate) with a
distance from eyes to screen of 70 cm. A chin rest was used
to minimize head movements. At the Bonn assessment site,
movements of the right eye were recorded using the EyeLink
1,000 system (SR Research, Mississauga, Ontario, Canada) at
a sampling frequency of 1,000Hz, whereas in Berlin, eye
movements were recorded using the EyeLink II system (SR
Research, Mississauga, Ontario, Canada) at a sampling rate of
250Hz. Before the task started, the eye-tracker was calibrated
with a five-point calibration task (0◦, horizontal± 13.3◦, vertical
± 9.3◦).
Saccade Tasks
The saccade task was programmed with SR Research’s
Experiment Builder (version 1.10.1241). Pro- and antisaccades
were evaluated via a blocked task design, with each block
comprising 60 trials. At the beginning of each trial, participants
were required to look at a central fixation cue (width and height:
0.46◦), which remained on screen throughout each trial (overlap
paradigm). After a random interval of 1,000–2,000ms, a target
stimulus (width and height: 0.46◦) appeared in either the left
or the right periphery at an angle of 16◦ and remained there
for 800ms. In the prosaccade block, subjects were instructed
to make a saccade toward the peripheral target as fast and
accurately as possible, whereas in the antisaccade block, subjects
were required to make a saccade in the direction opposite
of the target. Five practice trials were presented before each
block in which the experimenter ensured that the subject had
understood the instructions correctly. All stimuli were presented
on a black background. Pro- and antisaccade blocks appeared
in a fixed order as the strong main effect of task (latency of
antisaccades > prosaccades) is well-established throughout the
literature (52). Tasks were part of a larger oculomotor battery
with additional tasks, of which the results were already (53, 54)
and will be reported elsewhere.
Eye Movement Analysis
Saccades were identified according to SR Research’s saccade
detection algorithm (Data Viewer, version 1.11.900) and
individually verified by a rater. Criteria for the identification of
saccades were a velocity > 30◦/s, an acceleration > 8,000◦/s2,
a minimum amplitude of 1◦ and a minimum latency to the
peripheral stimulus of 80ms (55). Trials including oculomotor
events, i.e., saccades or blinks, <100ms before stimulus onset
were also excluded to ensure that subjects did not miss the onset
of stimulus presentation [e.g., (56); on average 3.5% of trials were
excluded in OCD patients, 4.6% in relatives and 2.8% in controls
due to anticipatory eye movements]. Furthermore, trials were
discarded if the gaze position at saccade onset deviatedmore than
2.3◦ (100 pixels) from the fixation stimulus position. Six subjects,
who performed <15 valid trials for either of the tasks, were
excluded from the analyses (57). For each subject, mean latencies
and ISV of correctly performed pro- and antisaccades were
calculated. Error rates were square-root transformed in order to
obtain normal distribution and further subdivided into errors
with express latency (≤130ms) and regular latency [>130ms;
(55, 58)].
Statistical Analyses
Statistical analyses were conducted using the Statistical Package
for the Social Sciences (SPSS) Release 23.0 (SPSS Inc., Chicago,
IL, USA). To test the hypothesis of impaired antisaccade
performance in OCD patients, we conducted 2 × 2 analyses
of variance (ANOVA) with group as the between-subjects
factor (OCD patients vs. healthy comparison subjects) and task
condition (prosaccades vs. antisaccades) as the within-subjects
factor. Two distinct ANOVAs were carried out with mean
saccade latency and ISV, i.e., SD, of saccades as dependent
variables. In order to disentangle the interaction effects, post-
hoc t-tests were conducted. Group differences in error rates were
investigated with one-way ANOVAs. Results from these analyses
were included in the combined meta-analysis, as described in
section Statistical Methods.
Antisaccade performance of unaffected relatives was assessed
via similar analyses. As relatives were significantly older than
OCD patients and healthy volunteers, and age had a strong
impact on saccade performance, it was included as a covariate
for all ANOVAs that comprised relatives. To further support
these results, additional analyses were conducted comparing
unaffected relatives and a subsample of age-matched control
subjects (n= 96).
Associations with specific OCD symptom dimensions were
investigated using the Y-BOCS CL. Following the procedure
established in previous studies (24, 59), the 13 main categories of
the Y-BOCS CL were coded as 1 if the patient reported having
experienced at least one symptom of the respective category.
Otherwise, the category was coded as 0. These binary variables
were then fed into an exploratory principal component analysis
(PCA) with varimax rotation. Factors were extracted based on the
Kaiser-Guttmann criterion, i.e., eigenvalue > 1. For each OCD
patient, factor scores were exported for utility in further analyses.
Pearson’s correlation coefficients were computed in order to
explore relationships between mean saccade latencies and ISV,
antisaccade error rates and continuous clinical variables. Group
differences in demographic and clinical characteristics were
tested using ANOVAs and Fisher’s chi-square test was utilized to
compare sex ratios across groups.We also performed exploratory
ANOVAs using medication [medication-naïve (n = 65) vs. any
psychoactive medication within the past 4 weeks (n = 81) vs.
previous psychoactive medication but not within the past 4
weeks (n = 23)] and depressive comorbidity [current episode
of major depression (n = 37) vs. remitted major depression
(n = 66) vs. no lifetime diagnosis of major depression (n = 64)]
as the between-subjects factor in OCD patients. Moreover,
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analyses were rerun excluding all OCD patients with current
comorbid anxiety disorders, i.e., specific phobia, social phobia,
panic disorder with/without agoraphobia and generalized anxiety
disorder (n = 35). To investigate whether significant group
differences in antisaccade performance were driven by increased
levels of anxiety, correlations with state anxiety and harm
avoidance were computed. The alpha level was set to 0.05 for all
primary statistical analyses. In the correlation analysis evaluating
OCD symptom dimensions, Bonferroni correction was applied
to account for multiple comparisons.
Meta-Analysis
Study Selection for Meta-Analysis
We conducted a systematic, comprehensive literature search
of the PubMed database for relevant, full-length articles
published up to the 30th April 2017 with the following search
expressions: (“obsessive-compulsive disorder” OR “OCD” OR
“obsessive-compulsive”) AND (“antisaccade” OR “anti-saccade”
OR “saccade” OR “saccadic eye movement”). Publication
reference lists of identified articles were searched as well. Only
original research articles written in English and published in
peer-reviewed journals were considered. The included studies
were strictly those which made use of either video-oculography
or electrooculography (EOG) to assess antisaccades. Studies
employing complex picture stimuli as peripheral targets instead
of simple cues were excluded. All studies were required to
feature one group of individuals classified as having OCD
based on a standardized clinical interview and one group
of healthy (i.e., screened for the absence of a psychiatric
or neurologic diseases) control subjects. Studies examining
patient populations overlapping with previous publications were
excluded. A flowchart showing the procedure of study selection
according to the aforementioned criteria and PRISMA guidelines
(60) is presented in Figure 1.
Data Extraction
From each study, means and SDs or results from statistical tests
(t, F, and p statistics) were extracted to compute the standardized
mean difference (Cohen’s d) in antisaccade latencies and error
rates. As only one study reported ISV of antisaccade latencies
and no study has investigated express and regular errors thus
far, these measures could not be considered for meta-analysis.
Additionally, we extracted the year of publication of each study,
samples size, sex ratio as well as means and SDs of age and verbal
intelligence quotient (IQ; or measures of education). If available,
information on symptom severity as evaluated by Y-BOCS,
the proportion of patients receiving psychotropic medication,
the proportion of patients with comorbid depressive disorders,
depressive symptom severity (e.g., according to the Hamilton
Depression Rating Scale; HAM-D), age of OCD onset and task
characteristics were extracted, too. The variables recorded were
cross-verified by two researchers.
One study did not describe the main effect of group on
antisaccade error rates but only the group × target amplitude
interaction (20). As it was not possible to derive mean values and
SDs across all three target amplitude conditions (8, 16, and 24◦)
from the information given, only results from the 16◦ condition
were included in the meta-analysis. Similarly, McDowell and
Clementz (19) reported statistics separately for each fixation cue
condition (step, gap, overlap). For the sake of comparability with
the present study’s findings, data from the overlap condition
were included in the meta-analysis. Furthermore, Agam et al.
(14) reported antisaccade data from the same sample once
acquired during electroencephalography (EEG) and once during
functional magnetic resonance imaging (fMRI). As the EEG
session was performed first, included more antisaccade trials
and was presumably more comparable to the setup of the other
studies, antisaccade data acquired during EEG were part of the
present meta-analysis. Data from Maruff et al. (18) were read
off figures as precisely as possible because the exact values could
FIGURE 1 | Flowchart showing the process of article selection. OCD, obsessive-compulsive disorder.
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not be retrieved. Finally, two studies used square-root (17) and
logit transformations (14), respectively, in order to obtain normal
distributions of error rates. In these cases, effect sizes derived
from analyses of the transformed values were featured in the
meta-analysis, instead of raw values.
Statistical Methods
Meta-analyses were conducted using the R-based software
OpenMetaAnalyst (61). Effect sizes of outcome variables were
estimated by computing the standardized mean difference
(SMD), which is a measure of effect size calculated by subtracting
the control group’s mean from the OCD group’s mean and
dividing by the pooled SD. For each outcome measure within
a study, i.e., antisaccade error rates and latencies, separate
effect sizes were computed. Positive effect sizes indicated
worse oculomotor functioning, i.e., higher error rates or longer
latencies, in theOCD group relative to the control group, whereas
negative effect sizes suggested better performance in OCD
patients. With few exceptions, effect sizes were calculated directly
from means and SDs reported in studies. When this information
was not available, results of other statistical tests (e.g., t and
F statistics) were consulted to calculate effect size (62). A
weighted-average effect size was then computed for each outcome
variable using the Hedges-Olkin random-effects method (63). To
determine whether effect sizes were consistent across studies, we
calculated the homogeneity statistics, Q and I2, where I2 = [(Q-
df)/Q] × 100%, which describes the proportion of the variability
in effect estimates that emanated from heterogeneity rather than
sampling error.
Moreover, several meta-regressions were performed with
mean age, proportion of males, proportion of medicated patients,
mean Y-BOCS scores, task design (gap, step, overlap), number
of trials, target amplitude and mean cue latency as moderators
in order to investigate systematic influences of sample and task
characteristics on antisaccade error rates and latencies.
RESULTS
Empirical Study
Effects of Task, Age and Study Site
Mean saccade latencies were significantly faster for the
prosaccade task than the antisaccade task [F(1, 451) = 1426.64,
p < 0.001, η2 = 0.76, 95% CI (0.73, 0.79)]. A main effect of age
indicated that saccade latencies rose with age [F(1, 450) = 58.65,
p < 0.001, η2 = 0.12, 95% CI (0.07, 0.17)]. Likewise, analysis
of ISV of saccade latencies revealed a main effect of task type
[F(1, 451) = 135.08, p < 0.001, η
2 = 0.23, 95% CI (0.17, 0.29)]
with smaller ISV for the prosaccade task than the antisaccade
task. ISV of saccade latencies significantly increased with age,
as well [F(1, 450) = 25.59, p < 0.001, η
2 = 0.05, 95% CI (0.02,
0.10)]. Importantly, there was no effect of study site on any of
the examined saccade variables (all p > 0.05).
Saccade Performance in OCD Patients and Healthy
Comparison Subjects
Comparing mean saccade latencies between OCD patients and
healthy controls yielded a significant group-by-task interaction
[F(1, 350) = 10.76, p = 0.001, η
2 = 0.03, 95% CI (0.005,
0.07)]. In particular, patients had longer antisaccade latencies
[t(350) = 2.05, p = 0.042, d = 0.22, 95% CI (0.01, 0.43)],
while there was no difference in prosaccade latencies between
patients and controls [t(329.08) = −1.32, p = 0.19, d = 0.14,
95% CI (−0.07, 0.01)]. Analysis of ISV yielded a significant
effect of group [F(1, 350) = 10.42, p = 0.001, η
2 = 0.03,
95% CI (0.004, 0.07)] along with a significant group-by-task
interaction [F(1, 350) = 14.74, p < 0.001, η
2 = 0.04, 95% CI (0.01,
0.09)] indicative of OCD patients exhibiting higher ISV in the
antisaccade task compared to healthy controls [t(315.39) = 4.06,
p < 0.001, d = 0.44, 95% CI (0.23, 0.65); Figure 2], while ISV
of prosaccades did not differ between groups [t(350) = 1.01,
p = 0.31, d = 0.11, 95% CI (−0.10, 0.32)]. Furthermore, patients
made significantly more errors in the antisaccade task than
controls [t(322.47) = 2.09, p = 0.037, d = 0.22, 95% CI (0.01,
0.43)]. This effect was driven by express errors [t(309.94) = 2.49,
p= 0.013, d = 0.27, 95% CI (0.06, 0.48)], as groups did not differ
significantly regarding regular errors [t(350) = 1.17, p = 0.24,
d = 0.12, 95% CI (−0.08, 0.33); Figure 3].
Saccade Performance in Unaffected Relatives
Unaffected relatives did not differ from control subjects with
regards to pro- and antisaccade latencies (p > 0.05 for both
the main effect of group and the group-by-task interaction).
However, relatives exhibited significantly higher ISV of latencies
across tasks [F(1, 280) = 4.62, p = 0.033, η
2 = 0.02, 95% CI (0.0,
0.06); Figure 2]. While the group difference in overall error rate
did not reach significance [F(1, 280) = 1.40, p = 0.24, η
2 = 0.005,
95%CI (0.0, 0.03)], separate analyses of express and regular errors
suggested a significant effect of group on the rate of express
FIGURE 2 | Intra-subject variability, i.e., SDs, of pro- and antisaccade
latencies in patients with obsessive-compulsive disorder (OCD), unaffected
first-degree relatives and healthy control subjects. Age is included as a
covariate and values are depicted for a mean age of 36.37 years. Error bars
indicate standard errors. The effect of group and the group by task interaction
are significant at p = 0.002 and p = 0.001, respectively.
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FIGURE 3 | Express and regular error rates in the antisaccade task in patients
with obsessive-compulsive disorder (OCD), unaffected first-degree relatives
and healthy control subjects. Age is included as a covariate and values are
depicted for a mean age of 36.37 years. Error bars indicate standard errors.
Groups differ significantly regarding express errors (p = 0.007), but not
regarding regular errors (p = 0.45).
errors [F(1, 280) = 7.71, p = 0.006, η
2 = 0.03, 95% CI (0.002,
0.07)] but not on the rate of regular errors [F(1, 280) = 0.29,
p = 0.59, η2 = 0.001, 95% CI (0.0, 0.02); Figure 3]. Relatives did
not significantly differ fromOCD patients across all measures (all
p > 0.05).
These results were supported by additional analyses
comparing unaffected relatives to a subsample of age-matched
controls (n = 96). Groups did not differ with regards to pro-
and antisaccade latencies (p > 0.05 for both the main effect
of group and the group-by-task interaction), but relatives
exhibited significantly higher ISV of latencies across tasks
[F(1, 194) = 6.33, p = 0.013, η
2 = 0.03, 95% CI (0.0, 0.09)].
Again, the group difference in overall error rate did not reach
significance [t(194) = 1.84, p = 0.07, d = 0.26, 95% CI (−0.02,
0.54)], while separate analyses of express and regular errors
yielded a significant effect of group on the rate of express errors
[t(186.88) = 2.93, p= 0.004, d = 0.42, 95% CI (0.14, 0.70)] but not
on the rate of regular errors [t(194) = 1.32, p = 0.19, d = 0.19,
95% CI (−0.09, 0.47)].
Effects of Medication, Depressive Comorbidity, and
OCD Severity
Analyses of OCD patients with current, previous and no history
of major depression did not yield any significant effects (all
p > 0.05). Moreover, patients taking psychoactive medication
did not differ from previously and never-medicated patients
regarding antisaccade latencies, ISV and error rates (all p> 0.05).
There were no significant associations between symptom severity
as assessed by Y-BOCS or any of the saccade performance
measures, either (all p > 0.05).
Effects of Anxiety
Excluding OCD patients with current comorbid anxiety
disorders did not alter the results substantially. Furthermore,
there were no significant correlations between state anxiety and
antisaccade performance in either OCD patients, unaffected
relatives, or healthy controls (all p > 0.05). While we did
not observe any associations between harm avoidance and
antisaccade parameters in OCD patients and healthy controls
(all p> 0.05), there was a significant positive correlation between
harm avoidance and antisaccade error rate (r = 0.23, p = 0.020)
in relatives, which was particularly pronounced with regards to
express errors (r = 0.30, p= 0.002).
Symptom Dimensions
PCA of Y-BOCS CL items yielded five factors representing the
dimensions of ordering/symmetry/counting, checking/intrusive
thoughts (aggression, religion, body), washing/contamination,
hoarding and repeating/sexual obsessions. After controlling
for multiple comparisons, none of the correlations between
symptom dimensions and antisaccade performance parameters
reached significance.
Meta-Analysis
Meta-Analysis of Previous Studies
After standardized study selection (Figure 1), 10 studies were
included in the meta-analysis with a total of 189 OCD patients
and 204 control subjects. Samples and task characteristics are
presented in Tables 2, 3.
Meta-analysis of antisaccade error rates yielded a weighted-
average SMD of 0.55 [95% CI (0.28, 0.81), p < 0.001].
According to the Q and I2 statistics, results across the
studies were moderately, though not significantly, heterogeneous
[Q(9) = 12.71, I
2 = 35.32%, p = 0.18]. As indicated by the meta-
regressions, there was no significant impact of age (b = 0.012,
p = 0.55), gender (b = 0.002, p = 0.74), medication (b = 0.45,
p = 0.24) and Y-BOCS score (b = 0.024, p = 0.67). In terms of
task characteristics, there was no effect of task design (p = 0.95),
number of trials (b = 0.001, p = 0.60), target amplitude
(b = −0.015, p = 0.68) and mean cue latency (b = 0.000,
p= 0.095).
Meta-analysis of antisaccade latencies yielded a similar SMD
of 0.56, but the effect did not reach significance [95% CI
(−0.06, 1.17), p= 0.075] as considerable statistical heterogeneity
was observed [Q(8) = 36.12, I
2 = 87.26%, p < 0.001]. Meta-
regressions using mean age (b= 0.067, p= 0.078), proportion of
males (b = −0.006, p = 0.67), proportion of medicated patients
(b = −0.17, p = 0.83) and mean Y-BOCS scores (b = 0.16,
p = 0.20) as moderators did not yield any significant effects on
SMD. Furthermore, there was no effect of task design (p = 0.95),
number of trials (b = −0.001, p = 0.80), target amplitude
(b= 0.006, p= 0.94) and mean cue latency (b= 0.001, p= 0.16).
Meta-Analysis of Previous and the Present Empirical
Study
Including the present empirical study in the meta-analysis of
antisaccade error rates yielded a weighted-average SMD of 0.48
[95% CI (0.24, 0.72), p < 0.001; Figure 4A]. Again, we noted
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TABLE 3 | Task characteristics and results of the 10 studies included in the meta-analysis.
Author
(year)
Task design n of trials Target
amplitude
Cue latencies Results: mean
latencies
Results: error rates Results: SD
of latencies
(22) step 10–16 ∼10◦ – – OCD > CON –
(19) step, gap, or 200ms overlap 120 10, or 20◦ 2,000–2,500ms OCD > CON OCD = CON –
(20) step 36 8, 16, or 24◦ 1,500–2,500ms OCD = CON OCD > CON (8◦)
OCD = CON (16◦)
OCD = CON (24◦)
–
(18) step 106 10, or 15◦ 2,000–2,500ms OCD > CON OCD = CON –
(21) step 20 12◦ 700, 1,000, or
1,300ms
OCD = CON OCD = CON –
(23) 200ms gap 50 7◦ 1,000ms OCD > CON OCD = CON –
(16) overlap 40 – 1,000–2,000ms OCD = CON OCD = CON –
(17) 200ms overlap 50 16◦ 1,500, 2,000,
2,500, or 3,000ms
OCD > CON (only
interaction term with
prosaccades)
OCD > CON –
(14) 200ms gap; 50% trials with
distractor; 40% without
distractor, 10% fake-hard;
twice: during fMRI and EEG
384 (EEG)
512 (fMRI)
10◦ 2,000ms OCD = CON (EEG)
OCD = CON (fMRI)
OCD = CON (EEG)
OCD > CON (fMRI)
–
(15) step 90 2–10◦
(1◦ intervals)
1,000–2,000ms OCD = CON OCD > CON OCD > CON
CON, healthy control subjects; OCD, obsessive-compulsive disorder; SD, standard deviation.
Hyphens indicate that the specific characteristic was not reported.
moderate, though non-significant, heterogeneity across studies
[Q(9) = 17.22, I
2 = 45.03%, p= 0.070]. As indicated by the meta-
regressions, there was no significant effect of age (b = 0.012,
p = 0.56), gender (b = 0.005, p = 0.34), medication (b = 0.55,
p = 0.15) and Y-BOCS score (b = 0.010, p = 0.86). While
there was no impact of task design (p = 0.84), number of
trials (b = 0.001, p = 0.48) and target amplitude (b = −0.04,
p = 0.050) on SMD, the effect of mean cue latency (b = 0.000,
p = 0.035) reached significance. Specifically, longer cue latencies
were associated with greater SMDs.
Meta-analysis of antisaccade latencies yielded a weighted-
average SMD of 0.51 [95% CI (−0.04, 1.06), p = 0.069;
Figure 4B]. The Q and I2 statistics indicate that results
across studies were significantly heterogeneous [Q(9) = 37.14,
I2 = 90.20%, p < 0.001]. Meta-regressions utilizing mean age
(b = 0.065, p = 0.072), proportion of males (b = −0.003,
p= 0.77), proportion of medicated patients (b=−0.18, p= 0.80)
and mean Y-BOCS scores (b = 0.14, p = 0.20) as moderators
did not yield any significant effects on SMD. With respect to
task characteristics, there was no effect of task design (p = 0.98),
number of trials (b = −0.000, p = 0.82), target amplitude
(b = −0.008, p = 0.91) and mean cue latency (b = 0.001,
p= 0.12).
DISCUSSION
The present study serves as an extensive investigation of
antisaccade performance in OCD patients and their unaffected
first-degree relatives. Convergent findings from meta-analysis
and a large empirical study indicate that patients with OCD
exhibit significantly increased error rates in the antisaccade
task while response latencies are not consistently elongated.
Whereas effect sizes for error rates and mean latencies appear
to be just moderate, we observed pronounced group differences
with regards to ISV of antisaccade latencies in OCD patients
as well as in unaffected relatives, providing the first evidence
for a potential endophenotype of OCD. Furthermore, detailed
analyses of error rates indicate that both patients and first-degree
relatives exhibit more express errors in the antisaccade task than
healthy controls.
Our findings highlight that antisaccade deficits in OCD
are substantial, but only of moderate effect size and limited
by inconsistencies across studies. The meta-analysis of 10
studies showed that patients with OCD feature a significantly
increased antisaccade error rate compared to matched healthy
controls. With regards to antisaccade latencies, however, the
group difference did not reach significance as there was large
heterogeneity across studies. As indicated by meta-regression,
age, gender, medication status and OCD severity did not
contribute to the variability in effect sizes, suggesting that OCD
patients’ deficits in the antisaccade task are not moderated
by demographic variables. This observation is in agreement
with the meta-analyses of cognitive function in OCD (64, 65)
and the absence of associations between patients’ medication
status, depressive comorbidity, OCD severity and oculomotor
performance in our empirical data. Still, other clinical variables
which are less state-dependent and more strongly related to
the genetic underpinnings of OCD, such as age of onset (66)
and symptom dimensions (67), could not be analyzed via meta-
regressions based on the small number of studies reporting
relevant information.With respect to our empirical investigation,
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FIGURE 4 | (A) Forest plot showing effect sizes for antisaccade error rates in patients with obsessive-compulsive disorder (OCD) as compared to healthy control
subjects. Higher values indicate higher error rates in patients. (B) Forest plot portraying the effect sizes for antisaccade latencies in patients with OCD as compared to
healthy control subjects. Higher values indicate longer latencies in patients.
however, we did not observe any significant correlations between
OCD symptom dimensions and antisaccade performance after
controlling for multiple comparisons.
While the majority of task characteristics did not affect SMD
as was indicated by the meta-regressions, the effect of mean
cue latency reached significance when the present empirical
study was included. Accordingly, longer mean cue latencies were
associated with greater group differences in error rates. Though
longer cue latencies are not generally associated with higher error
rates or an increased frequency of express saccades, OCD patients
and controls might be differentially affected by the manipulation
of cue latencies, resulting in a growing group difference.
Our empirical data indicate that the increased antisaccade
error rates in OCD patients are primarily driven by express
latency errors. As reviewed by Coe and Munoz (29), express and
regular errors arise from failures of different forms of suppression
mechanisms, which can be investigated via neurophysiological
experiments in macaques. At the start of an antisaccade trial, pre-
emptive top-down inhibition of saccade-generating neurons in
the frontal eye fields and the intermediate layers of the superior
colliculus (SCi) must be present before the stimulus appears in
order to prevent express errors. After the stimulus’ appearance,
voluntary antisaccade commands must compete with, and
override, automated visually initiated saccade commands to
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prevent longer latency errors. Potential sources of pre-stimulus
inhibition comprise fixation neurons within the SCi, which are
tonically active during visual fixation and cease firing during
the execution of saccades (68). Hence, the inhibition of neurons
in the SCi prior to stimulus elicitation is crucial to preventing
the initial visual transient response from triggering a direction
error (29). The CSTC model of OCD is in accordance with
the observed excess in express errors. Specifically, imbalances
between the direct and indirect CSTC pathways may not only
result in a reduced inhibition of the thalamus, but may also
contribute to a diminished inhibition of the SCi during the
antisaccade task, which may hence cease firing more easily and
facilitate the execution of quick, reflexive saccades toward the
target. Notably, oculomotor regions of the frontal cortex and
the basal ganglia also feature pre-stimulus activity, establishing
a form of top-down inhibition that appears to be required
for the inhibition of the SCi (29). A deficient transmission of
inhibitory signals from frontal regions to the SCi via the CSTC
circuitry may hence foster an increased frequency of express
error rates. Evidence from neuroimaging indicates that both
OCD patients and their unaffected relatives show aberrations
in CSTC functional connectivity (69), which may serve as the
basis for the increased express error rates we observed. In
conclusion, our findings support the role of the antisaccade error
rate as a potential endophenotype of OCD (17) and point to a
more particular mechanism, i.e., early pre-stimulus inhibition of
the SCi.
Aberrant CSTC function may also contribute to the increased
ISV of correct antisaccade latencies. To our knowledge, this is
the first study to demonstrate that ISV in antisaccade latencies
constitutes a potential endophenotype of OCD. While increased
SDs of antisaccade latencies have previously been described in
OCD patients (15), unaffected first-degree relatives have not been
evaluated thus far. In general, ISV in reaction times is most
strongly observed in tasks that require executive control (70),
indicating lapses of attention or cognitive control (71, 72). ISV of
response times is sensitive to frontal dysfunction (73), increased
in patients with schizophrenia (15) and also linked with the
genetic risk of schizophrenia (74). Considering the strong genetic
overlap between schizophrenia and OCD (75), endophenotypes
of schizophrenia could prove informative for OCD, as well. In
fact, endophenotypes have the potential to provide measures
that are sensitive to multiple diagnostic constructs, and may
aid the identification of shared pathomechanisms (76). Trans-
diagnostic approaches of neurocognitive endophenotypes have
been proposed, entailing instructive implications for the future
classification of psychiatric disorders, genetics and therapeutics
(77).
Twin studies of OCD and OCD-related traits yield heritability
estimates of roughly 50% (78, 79), but until now, the
identification of the specific genetic variants underlying this
heritability has been difficult. Two genome-wide association
studies (GWAS) studies and a recent meta-analysis of them did
not provide evidence for genome-wide significant hits (80–82),
possibly because of still insufficient sample sizes (n= 2,688 OCD
patients and n = 7,037 controls). In recent years, this issue has
been addressed by an endeavor to identify endophenotypes as
potential vulnerability factors of OCD, which are presumably
less genetically complex and hence more tractable to genetic
analysis. According to established criteria, an endophenotype
must: (a) be heritable; (b) be associated with the illness; (c) be
independent of clinical state; (d) co-segregate with the illness
within a family; and (e) represent reproducible measurements
(32, 76). Antisaccade performance, specifically error rates, meets
each of these criteria, rendering it a promising endophenotype
of OCD: (a) with heritability estimates ranging from 42 to
61%, antisaccades have a strong genetic component (83–85); (b)
antisaccade deficits have repeatedly been observed in patients
with OCD; (c) OCD symptom severity is not correlated with
antisaccade performance; (d) first-degree relatives of OCD
patients exhibit worse performance than healthy subjects from
the general population [(17); present study]; and (e) antisaccade
error rates and the SDs of antisaccade latencies are sufficiently
reliable (57, 86). Until now, antisaccade error rates are the most
commonly researched outcome measure in the antisaccade task,
while ISV of antisaccade latencies and express error rates have
rarely been examined in endophenotype studies. Our findings
highlight that OCD patients as well as their first-degree relatives
exhibit prolonged SDs of antisaccade latencies and increased
express error rates, independent of symptom severity. Further
research investigating the genetic basis of these more detailed
outcomemeasures is warranted. The genetic architecture of OCD
appears to be highly polygenetic and primarily constituted of
common variants (87, 88), with a SNP heritability that is among
the highest of all psychiatric disorders (89). Future studies may
look for associations between polygenic risk scores of OCD
and antisaccade performance so as to assess shared genetic
contributions. The identification of risk genes will contribute to
the understanding of etiological mechanisms in OCD and may
eventually point to new targets for medication.
In order to explore the potentially mediating role of anxiety,
we assessed correlations between antisaccade performance, state
anxiety, and harm avoidance, a personality trait that has
previously been discussed as an endophenotype of OCD [(90)
sample overlapping with the present sample; (91)]. While we
did not observe any associations between state anxiety and
antisaccade parameters within groups, there was a significant
positive correlation between harm avoidance and antisaccade
error rate in relatives, which was particularly pronounced with
regards to express errors. Hence, the underperformances we
observed in relatives of OCD patients appear to be driven by a
shared vulnerability expressed in an anxious personality rather
than by state anxiety. In accordance with the assumption of
pleiotropy, the genetic risk for OCD that is presumably reflected
in elevated scores of harm avoidance may at the same time
contribute to elevated antisaccade error rates.
Concerning antisaccade latencies, the findings are less
consistent. Although we observed slightly increased antisaccade
latencies in OCD patients within our empirical sample, meta-
analysis did not demonstrate a significant effect stemming from
large heterogeneity. While the majority of studies examined
antisaccade latencies without considering prosaccade latencies,
our results indicate that using a repeated-measures model,
including the saccade task as a between-subjects factor, yields
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more pronounced group differences between OCD patients and
controls. Whereas the mere comparison of antisaccade latencies
barely reached significance, including prosaccade latencies in
the model led to the observation of a strong group difference.
Though groups did not differ significantly with respect to
prosaccade latencies, the slightly faster prosaccades in patients
contributed to the extensive group-by-saccade-task interaction
effect. These results are in line with (17), who also observed
a more pronounced effect when a repeated-measures approach
was employed. Hence, disregarding prosaccades as a reference
task may explain why the overall latency effect did not reach
significance in the meta-analysis.
The present study is not without limitations. First, relatives
were significantly older than patients and controls. In order to
address this shortcoming, age was included as a covariate across
all analyses comprising relatives, and additional analyses were
conducted comparing relatives to an age-matched subsample
of control subjects. Notably, patients and controls were well-
matched with regards to age so the main analyses were
not affected by this issue. Furthermore, the mean age of
unaffected relatives lies well above the average age of onset of
OCD symptoms, making it very unlikely that the effects are
driven by subjects who will develop OCD later on. Second, a
substantial number of patients was medicated with SSRI or other
antidepressants. Though SSRI have been shown to influence
functional brain networks (92), they do not seem to affect
antisaccade performance (93). In line with this notion, we did
not observe significant differences between medication-naïve,
currently medicated and previously medicated OCD patients.
Third, asmany of the original studies appear to be underpowered,
the power of the meta-analyses is likely also relatively low.
In summary, combining meta-analysis of previous findings
with the assessment of a large and thoroughly characterized
empirical sample allowed for an extensive examination of
antisaccade performance in OCD while considering a large
variety of covariates, including medication status, depressive
comorbidity, comorbid anxiety disorders and OCD symptom
dimensions. Our results indicate that antisaccade deficits in OCD
are substantial, though of moderate effect size. Assessing more
detailed parameters, such as express error rates and ISV of
saccades, has shown to be informative, as we found first evidence
that an increased ISV of antisaccade latencies and an elevated rate
of express errors constitute potential endophenotypes of OCD.
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